main-img
Back to Home » August 2019 News » LenioBio won Prestigious Horizon 2020 SME/2 Grant

LenioBio won Prestigious Horizon 2020 SME/2 Grant

August 23, 2019

DUSSELDORF, Germany, Aug. 23, 2019 /PRNewswire/ -- LenioBio GmbH today announced that the company has been awarded a grant of €2.37 million to accelerate the scale-up of its proprietary protein expression platform ALiCE®. Today's drug development process is cumbersome and expensive. On...

Source URL: https://www.prnewswire.com:443/news-releases/leniobio-won-prestigious-horizon-2020-sme2-grant-300906250.html
Browse News